|
|
|
|
|
|
|
|
|
|
|
|
|
03.11.25 - 13:06
|
Bruker Reports Third Quarter 2025 Financial Results (Business Wire)
|
|
|
Q3 2025 revenues of $860.5 million, down 0.5% year-over-year (yoy), down 4.5% organically
Q3 2025 GAAP diluted loss per share $(0.41); non-GAAP diluted earnings per share (EPS) $0.45
Updated FY2025 guidance:
Revenue $3.41 to $3.44 billion; reported growth of 1-2% yoy, organic decline of 4-5%
Non-GAAP EPS $1.85 to $1.90
BILLERICA, Mass.--(BUSINESS WIRE)--$BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced financial results for the three and nine months ended September 30, 2025.
Frank H. Laukien, Bruker's President and CEO, commented: “In the third quarter, we were encouraged by our mid-single digit percentage organic bookings growth year-over-year, with a Scientific Instruments segment book-to-bill ratio greater than 1.0. For the first time this year, we saw strength in bookings in the academic/government market segment, as well as improving biopharma and applied markets orders. Notably, our innovative spatial biology, proteomics and multiomics solutions launched at AGBT and ASMS are being ...
|
|
|
|
|
|
|
|
|
|
|
|
|
02.10.25 - 23:27
|
Assessing Bruker: Insights From 6 Financial Analysts (Benzinga)
|
|
|
Latest Ratings for BRKR
DateFirmActionFromTo Feb 2022SVB LeerinkMaintainsOutperform Nov 2021Wells FargoMaintainsEqual-Weight Sep 2021SVB LeerinkMaintainsOutperform
View More Analyst Ratings for BRKR
View the Latest Analyst Ratings
read more...
|
|
|
21.09.25 - 21:21
|
XFRA: DIVIDEND/INTEREST INFORMATION - 23.09.2025 - US1167941087 (XETRA)
|
|
|
Das Instrument BKD US1167941087 BRUKER CORP. DL -,01 EQUITY wird cum Dividende/Zinsen gehandelt am 22.09.2025 und ex Dividende/Zinsen am 23.09.2025
The instrument BKD US1167941087 BRUKER CORP. DL -,01 EQUITY has its pre-dividend/interest day on 22.09.2025 and its ex-dividend/interest day on 23.09.2025...
|
|
|
|
|
|
|
|
|
04.09.25 - 05:42
|
Bruker Announces Pricing of Public Offering of $600 Million of 6.375% Mandatory Convertible Preferred Stock (Business Wire)
|
|
|
BILLERICA, Mass.--(BUSINESS WIRE)--$BRKR #BRKR--Bruker Corporation (“Bruker”) (Nasdaq: BRKR) today announced the pricing of its previously announced public offering of $600.0 million of 6.375% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share (the “Mandatory Convertible Preferred Stock”). Bruker has granted the underwriters a 30-day option to purchase up to an additional $90.0 million of Mandatory Convertible Preferred Stock. The offering is expected to close on or about September 8, 2025, subject to customary closing conditions.
Bruker estimates that the net proceeds from this offering will be approximately $582.0 million (or approximately $669.5 million if the underwriters exercise their option to purchase Mandatory Convertible Preferred Stock in full), in each case after deducting the underwriting discounts and commissions and estimated offering expenses payable by Bruker. Bruker intends to use the net proceeds from this offering to strengthen the balance sheet and enha...
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
